Prime Medicine, Inc. (PRME)
USD 1.32
(-6.74%)
USD 1.32
(-6.74%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -198.13 Million USD | -62.64% |
| 2022 | -121.82 Million USD | 26.33% |
| 2021 | -165.36 Million USD | -4749.47% |
| 2020 | -3.41 Million USD | -34.84% |
| 2019 | -2.52 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -45.76 Million USD | 30.29% |
| 2024 Q2 | -55.32 Million USD | -20.9% |
| 2023 FY | -198.13 Million USD | -62.64% |
| 2023 Q1 | -39.39 Million USD | -0.29% |
| 2023 Q2 | -42.38 Million USD | -7.58% |
| 2023 Q3 | -50.7 Million USD | -19.64% |
| 2023 Q4 | -65.64 Million USD | -29.45% |
| 2022 Q4 | -39.28 Million USD | -10.0% |
| 2022 Q3 | -35.71 Million USD | -0.2% |
| 2022 Q1 | -30.06 Million USD | 51.07% |
| 2022 Q2 | -35.64 Million USD | -18.55% |
| 2022 FY | -121.82 Million USD | 26.33% |
| 2021 Q3 | -22.77 Million USD | 0.0% |
| 2021 FY | -165.36 Million USD | -4749.47% |
| 2021 Q4 | -61.44 Million USD | -169.78% |
| 2020 FY | -3.41 Million USD | -34.84% |
| 2020 Q4 | -2.52 Million USD | 0.0% |
| 2019 FY | -2.52 Million USD | 0.0% |
| 2019 Q4 | -2.52 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -35.339% |
| Alkermes plc | 355.75 Million USD | 155.693% |
| Agenus Inc. | -245.76 Million USD | 19.38% |
| Aptorum Group Limited | -2.82 Million USD | -6914.434% |
| Ardelyx, Inc. | -66.06 Million USD | -199.897% |
| Dyadic International, Inc. | -6.79 Million USD | -2815.667% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -21068.056% |
| Lantern Pharma Inc. | -15.96 Million USD | -1141.316% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -941.222% |
| Novavax, Inc. | -545.06 Million USD | 63.649% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -239.892% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -168.509% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -968.327% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -1884.108% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -235.917% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 46.971% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -714.046% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -430.619% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -20.391% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -170.131% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -876.458% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -218.26% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -509.922% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -49.542% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 54.995% |
| AlloVir, Inc. | -190.41 Million USD | -4.052% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 3.479% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -596.376% |
| Bicycle Therapeutics plc | -180.66 Million USD | -9.669% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -10.656% |
| ChromaDex Corporation | -4.93 Million USD | -3912.414% |
| Chimerix, Inc. | -82.09 Million USD | -141.346% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -344.211% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -94.115% |
| CRISPR Therapeutics AG | -153.61 Million USD | -28.984% |
| Precision BioSciences, Inc. | -61.31 Million USD | -223.118% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -23.119% |
| Fortress Biotech, Inc. | -60.63 Million USD | -226.753% |
| Fortress Biotech, Inc. | -60.63 Million USD | -226.753% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -142.87% |
| ImmuCell Corporation | -5.77 Million USD | -3331.113% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -75.399% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1184.405% |
| Incyte Corporation | 597.59 Million USD | 133.155% |
| Innoviva, Inc. | 179.72 Million USD | 210.244% |
| IO Biotech, Inc. | -86.08 Million USD | -130.165% |
| Jaguar Health, Inc. | -41.3 Million USD | -379.741% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -29.505% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 479.9% |
| ContextLogic Inc. | -317 Million USD | 37.497% |
| MiMedx Group, Inc. | 67.43 Million USD | 393.796% |
| MEI Pharma, Inc. | 17.77 Million USD | 1214.484% |
| NextCure, Inc. | -62.72 Million USD | -215.886% |
| Onconetix, Inc. | -37.4 Million USD | -429.63% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -401.869% |
| Opthea Limited | -220.24 Million USD | 10.039% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -287.288% |
| Vaxcyte, Inc. | -402.26 Million USD | 50.746% |
| PDS Biotechnology Corporation | -42.94 Million USD | -361.395% |
| Precigen, Inc. | -95.9 Million USD | -106.595% |
| Pharming Group N.V. | -10.54 Million USD | -1778.394% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 1.716% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -707.289% |
| PureTech Health plc | -65.69 Million USD | -201.586% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -689.658% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 6.638% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -714.046% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 23.154% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -627.414% |
| Acelyrin, Inc. | -381.64 Million USD | 48.084% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1579569.114% |
| Summit Therapeutics Inc. | -614.92 Million USD | 67.779% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -481.018% |
| Senti Biosciences, Inc. | -92.91 Million USD | -113.232% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -89.241% |
| Elevation Oncology, Inc. | -45.7 Million USD | -333.513% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -463.839% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1415.721% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -2863.844% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -574.794% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2230.702% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -244.501% |
| Seer, Inc. | -86.27 Million USD | -129.648% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -195.743% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -201.274% |
| ESSA Pharma Inc. | -26.58 Million USD | -645.356% |
| GlycoMimetics, Inc. | -36.89 Million USD | -436.954% |
| GT Biopharma, Inc. | -7.59 Million USD | -2508.043% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 17.91% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -281.575% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 377.458% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -264.068% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -303.365% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -1891.738% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 65.412% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -5422.101% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -288.055% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 19.325% |
| Aptose Biosciences Inc. | -51.2 Million USD | -286.926% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -101.564% |
| Soligenix, Inc. | -6.14 Million USD | -3126.538% |
| Century Therapeutics, Inc. | -136.67 Million USD | -44.969% |
| Kura Oncology, Inc. | -152.63 Million USD | -29.812% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -122.077% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -1780.177% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 35138.64% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -34721.265% |
| Autolus Therapeutics plc | -208.38 Million USD | 4.919% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -175.575% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -179.869% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -814.404% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 12.039% |
| GRI Bio, Inc. | -13.03 Million USD | -1419.774% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -4692.097% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -59.677% |
| IGM Biosciences, Inc. | -246.41 Million USD | 19.594% |
| INmune Bio, Inc. | -30 Million USD | -560.267% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -79.21% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -369.579% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1141.306% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1154.405% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -231.964% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -95.847% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 28.245% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 16.713% |
| Verastem, Inc. | -87.36 Million USD | -126.782% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -265.64% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -22.808% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -69.841% |
| Histogen Inc. | -10.62 Million USD | -1765.483% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1286.83% |
| Surrozen, Inc. | -43.04 Million USD | -360.325% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1250.508% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -3794.867% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -278.557% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -684.281% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -635.515% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -2270.838% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -31.14% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -304.964% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -566.553% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -1801.887% |
| Apollomics, Inc. | -172.6 Million USD | -14.792% |
| Amarin Corporation plc | -59.11 Million USD | -235.182% |
| Mesoblast Limited | -87.95 Million USD | -125.264% |
| Turnstone Biologics Corp. | -55.2 Million USD | -258.937% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -34.819% |
| Synaptogenix, Inc. | -6.03 Million USD | -3181.16% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1122.44% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -153.952% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4035.123% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -2258.11% |
| Exelixis, Inc. | 207.76 Million USD | 195.364% |
| Better Therapeutics, Inc. | -39.76 Million USD | -398.322% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -37.642% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 62.519% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1527.773% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -2441.897% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -544.356% |
| Gritstone bio, Inc. | -138.49 Million USD | -43.067% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -207.35% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -4853.387% |
| Avid Bioservices, Inc. | -140.75 Million USD | -40.766% |
| Insmed Incorporated | -749.56 Million USD | 73.567% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1204.407% |
| MediWound Ltd. | -6.71 Million USD | -2850.164% |
| OmniAb, Inc. | -50.61 Million USD | -291.42% |
| Alector, Inc. | -130.39 Million USD | -51.953% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -74.223% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -282.149% |
| Zai Lab Limited | -334.62 Million USD | 40.789% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 38.845% |
| Aura Biosciences, Inc. | -76.4 Million USD | -159.309% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 15.556% |
| Immunic, Inc. | -93.61 Million USD | -111.653% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -45.801% |
| Veracyte, Inc. | -74.4 Million USD | -166.293% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -2481.352% |
| FibroGen, Inc. | -284.23 Million USD | 30.292% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -655.31% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -2729.707% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -952.069% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 147.762% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -778.444% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 502.129% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1663.55% |
| Galecto, Inc. | -38.34 Million USD | -416.658% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -950.212% |
| Fortrea Holdings Inc. | -3.4 Million USD | -5727.441% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -56.449% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1037.976% |
| XBiotech Inc. | -24.55 Million USD | -706.829% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -207.35% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -216.102% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -101.301% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -824.688% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -258.982% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 67.339% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -190.283% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -347904.707% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 12.539% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -789.785% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 9.821% |
| NexImmune, Inc. | -32.34 Million USD | -512.573% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -3647.853% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1310.611% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 105.011% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -718.022% |
| Scopus BioPharma Inc. | -11.6 Million USD | -1606.597% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -69.637% |
| Ainos, Inc. | -13.77 Million USD | -1338.817% |
| Pluri Inc. | -20.88 Million USD | -848.549% |
| Prothena Corporation plc | -147.02 Million USD | -34.759% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -73.998% |
| Celularity Inc. | -196.29 Million USD | -0.936% |
| Rallybio Corporation | -74.56 Million USD | -165.722% |
| Cue Biopharma, Inc. | -50.73 Million USD | -290.541% |
| MeiraGTx Holdings plc | -84.02 Million USD | -135.797% |
| Omeros Corporation | -117.81 Million USD | -68.176% |
| Humacyte, Inc. | -110.77 Million USD | -78.859% |
| Immunocore Holdings plc | -55.28 Million USD | -258.372% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1001.718% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -764.04% |
| Blueprint Medicines Corporation | -506.98 Million USD | 60.919% |
| CalciMedica, Inc. | -34.35 Million USD | -476.689% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -192.771% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -40.117% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -19.509% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 30.051% |
| Pulmatrix, Inc. | -14.12 Million USD | -1303.109% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -462.958% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -139.76% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 58.825% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -88.93% |
| Cytokinetics, Incorporated | -526.24 Million USD | 62.35% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -449.378% |
| Nutriband Inc. | -5.48 Million USD | -3512.063% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -390.186% |
| Vor Biopharma Inc. | -117.86 Million USD | -68.104% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 104.556% |
| Evogene Ltd. | -23.87 Million USD | -729.737% |
| ProKidney Corp. | -35.46 Million USD | -458.625% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -65.438% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -2425.47% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 69.196% |
| CorMedix Inc. | -46.33 Million USD | -327.571% |
| BioLineRx Ltd. | -60.61 Million USD | -226.877% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -94.737% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -382.475% |
| Atai Life Sciences N.V. | -40.22 Million USD | -392.574% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -145.67% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -162.355% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 32.191% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -610.766% |
| MediciNova, Inc. | -8.57 Million USD | -2211.528% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -60.722% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2265.249% |
| GeoVax Labs, Inc. | -25.96 Million USD | -663.025% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 17.182% |
| Biomea Fusion, Inc. | -117.25 Million USD | -68.976% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 68.38% |
| Mereo BioPharma Group plc | -29.46 Million USD | -572.412% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -29.362% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 5.363% |
| Absci Corporation | -110.56 Million USD | -79.199% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -557.158% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -96.488% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 16.023% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1506.795% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -2.68% |
| Allakos Inc. | -185.7 Million USD | -6.695% |
| Imunon, Inc. | -19.51 Million USD | -915.287% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -103.558% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 286.671% |
| BioAtla, Inc. | -123.46 Million USD | -60.481% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1527.773% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1132.324% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 39.458% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -436.234% |
| XOMA Corporation | -40.83 Million USD | -385.251% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -94.496% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -67.183% |
| aTyr Pharma, Inc. | -50.38 Million USD | -293.207% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -125.975% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -30.558% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 16.658% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -464.176% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -2348.523% |
| Akari Therapeutics, Plc | -10 Million USD | -1879.746% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -294193.353% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 170.361% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2872.783% |
| UroGen Pharma Ltd. | -102.24 Million USD | -93.784% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -85.53% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -2447.619% |
| Orgenesis Inc. | -55.36 Million USD | -257.893% |
| Entera Bio Ltd. | -8.88 Million USD | -2128.968% |
| GH Research PLC | -35.58 Million USD | -456.757% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -850.734% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -156.025% |
| Xencor, Inc. | -126.08 Million USD | -57.14% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -5161.516% |
| Replimune Group, Inc. | -215.79 Million USD | 8.184% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -831.666% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 7996.891% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2872.783% |
| Portage Biotech Inc. | -75.33 Million USD | -162.989% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2265.249% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -104.99% |
| OncoCyte Corporation | -27.78 Million USD | -613.196% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1376.708% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -1681.528% |
| Purple Biotech Ltd. | -19.88 Million USD | -896.645% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -2722.81% |
| scPharmaceuticals Inc. | -54.81 Million USD | -261.491% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1031.791% |
| HilleVax, Inc. | -123.56 Million USD | -60.346% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -1860.354% |
| Tharimmune, Inc. | -9.31 Million USD | -2026.097% |
| Genprex, Inc. | -30.86 Million USD | -542.029% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 16.019% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -558.38% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -11018.575% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -3641.171% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1177478.503% |
| Savara Inc. | -54.69 Million USD | -262.231% |
| Curis, Inc. | -47.41 Million USD | -317.887% |
| Daré Bioscience, Inc. | -30.16 Million USD | -556.909% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1182.822% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -3457.784% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -564.541% |
| BeiGene, Ltd. | -881.7 Million USD | 77.529% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -830.464% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 54.595% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -150.944% |
| Erasca, Inc. | -125.04 Million USD | -58.453% |
| bluebird bio, Inc. | -211.91 Million USD | 6.503% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -3862.266% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 218.186% |
| DBV Technologies S.A. | -72.72 Million USD | -172.438% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -3862.266% |
| Moderna, Inc. | -4.71 Billion USD | 95.797% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -393.396% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -3379.68% |
| Molecular Templates, Inc. | -8.12 Million USD | -2338.86% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -228.1% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -77.859% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -46.384% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -313.475% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -40.094% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -2.974% |
| MacroGenics, Inc. | -9.05 Million USD | -2087.381% |
| RenovoRx, Inc. | -10.23 Million USD | -1836.405% |
| Adicet Bio, Inc. | -142.65 Million USD | -38.887% |
| Aditxt, Inc. | -32.38 Million USD | -511.883% |
| Adagene Inc. | -18.94 Million USD | -945.757% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2609.799% |
| Quantum-Si incorporated | -95.96 Million USD | -106.475% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -66.458% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1259.145% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 249.726% |
| SciSparc Ltd. | -5.12 Million USD | -3768.274% |
| Vericel Corporation | -3.18 Million USD | -6126.681% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -164662.087% |
| Minerva Neurosciences, Inc. | -30 Million USD | -560.326% |
| Generation Bio Co. | -126.61 Million USD | -56.488% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -171.821% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -140.33% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 24.417% |
| Invivyd, Inc. | -198.64 Million USD | 0.257% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 42.062% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2180.911% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 968.776% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -1906.613% |
| 2seventy bio, Inc. | -217.57 Million USD | 8.934% |
| ADMA Biologics, Inc. | -28.23 Million USD | -601.629% |
| Clene Inc. | -49.5 Million USD | -300.236% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -788.985% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -300.803% |
| GeoVax Labs, Inc. | -25.96 Million USD | -663.025% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 39.606% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -508.836% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 972.064% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -100.556% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -165.047% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -23.213% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 67.786% |
| Evaxion Biotech A/S | -22.12 Million USD | -795.516% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -145.408% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 0.967% |
| Trevena, Inc. | -40.28 Million USD | -391.779% |
| Surrozen, Inc. | -43.04 Million USD | -360.325% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -186.593% |
| Cingulate Inc. | -23.53 Million USD | -741.867% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -2766.508% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -397.072% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -2469.594% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -119.635% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -223.292% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -232.98% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1557.319% |
| Kronos Bio, Inc. | -112.67 Million USD | -75.848% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -186.332% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -7812006.946% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -130.669% |
| Statera Biopharma, Inc. | -174.4 Million USD | -13.603% |
| ImmunityBio, Inc. | -583.19 Million USD | 66.026% |
| Korro Bio, Inc. | -81.17 Million USD | -144.09% |
| Kineta, Inc. | -14.09 Million USD | -1305.298% |
| BioVie Inc. | -32.12 Million USD | -516.842% |
| Codexis, Inc. | -76.24 Million USD | -159.881% |
| Celularity Inc. | -196.29 Million USD | -0.936% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 7.643% |
| Celcuity Inc. | -63.77 Million USD | -210.655% |
| Virax Biolabs Group Limited | -6.73 Million USD | -2842.48% |
| Cibus, Inc. | -267.62 Million USD | 25.967% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -391.328% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -453.274% |
| IN8bio, Inc. | -30 Million USD | -560.289% |
| Kodiak Sciences Inc. | -260.49 Million USD | 23.939% |
| Annexon, Inc. | -134.23 Million USD | -47.599% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -69.106% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -223.599% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -528.116% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 45.908% |
| Eyenovia, Inc. | -27.26 Million USD | -626.798% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1017.665% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -36934.206% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -159.323% |
| Arcellx, Inc. | -70.69 Million USD | -180.284% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -378.109% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -48.064% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -559.63% |
| Moolec Science SA | -51.78 Million USD | -282.578% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -278.326% |
| Geron Corporation | -184.12 Million USD | -7.607% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -372.037% |
| Royalty Pharma plc | 1.13 Billion USD | 117.459% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -45.733% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -2128.266% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -832.688% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -15.415% |
| Humacyte, Inc. | -110.77 Million USD | -78.859% |
| Structure Therapeutics Inc. | -89.62 Million USD | -121.081% |
| 89bio, Inc. | -142.18 Million USD | -39.345% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -187.316% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -1809.348% |
| Genelux Corporation | -28.29 Million USD | -600.191% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -581.689% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -11.864% |
| Notable Labs, Ltd. | -11.26 Million USD | -1658.993% |
| Liquidia Corporation | -78.5 Million USD | -152.392% |
| Mustang Bio, Inc. | -51.6 Million USD | -283.964% |
| Immunovant, Inc. | -259.33 Million USD | 23.6% |
| Quantum-Si incorporated | -95.96 Million USD | -106.475% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -171.978% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -922.305% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -106.41% |
| Acasti Pharma Inc. | -12.85 Million USD | -1441.531% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -782.243% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1141.306% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -8.63% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -4506.119% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1488.877% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -571.842% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -408.19% |
| PepGen Inc. | -78.62 Million USD | -151.994% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -565.568% |
| United Therapeutics Corporation | 984.8 Million USD | 120.119% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -790.085% |
| Solid Biosciences Inc. | -96.01 Million USD | -106.356% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4035.123% |
| Immuneering Corporation | -53.47 Million USD | -270.539% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -3794.867% |
| Silo Pharma, Inc. | -3.7 Million USD | -5253.958% |
| Belite Bio, Inc | -31.63 Million USD | -526.369% |
| XOMA Corporation | -40.83 Million USD | -385.251% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -264.45% |
| Bionomics Limited | -15.49 Billion USD | 98.721% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -135.915% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -579.538% |
| uniQure N.V. | -308.47 Million USD | 35.771% |
| Cassava Sciences, Inc. | -97.21 Million USD | -103.805% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2609.799% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -60.523% |
| Forte Biosciences, Inc. | -31.47 Million USD | -529.473% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -2315.754% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -581.619% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -36934.206% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -655.31% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1101.899% |
| Altimmune, Inc. | -88.44 Million USD | -124.013% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -30.708% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -579.538% |
| Compugen Ltd. | -18.75 Million USD | -956.484% |
| Peak Bio, Inc. | -1259.26 USD | -15733981.921% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -330.266% |
| Benitec Biopharma Inc. | -21.75 Million USD | -810.914% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 41.517% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -138.847% |
| Zura Bio Limited | -60.36 Million USD | -228.252% |
| PolyPid Ltd. | -23.86 Million USD | -730.224% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1159.427% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -138.847% |
| Instil Bio, Inc. | -156.08 Million USD | -26.938% |
| argenx SE | -295.05 Million USD | 32.848% |
| Immunome, Inc. | -106.8 Million USD | -85.507% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -366.261% |
| Verona Pharma plc | -54.36 Million USD | -264.423% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -98.298% |
| Shattuck Labs, Inc. | -87.29 Million USD | -126.962% |
| CervoMed Inc. | -2.17 Million USD | -9022.679% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -58.95% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1387.932% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -354.903% |
| Moolec Science SA | -51.78 Million USD | -282.578% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1145725.201% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -46.638% |
| AnaptysBio, Inc. | -163.61 Million USD | -21.094% |
| Design Therapeutics, Inc. | -66.86 Million USD | -196.331% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -143.365% |
| NeurAxis, Inc. | -14.62 Million USD | -1254.6% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -423.027% |
| Lumos Pharma, Inc. | -34.03 Million USD | -482.162% |
| Achilles Therapeutics plc | -69.66 Million USD | -184.408% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -98.298% |
| 180 Life Sciences Corp. | -19.93 Million USD | -893.89% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 6685.139% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -7812006.946% |
| Nutriband Inc. | -5.48 Million USD | -3512.063% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -96.762% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -307.622% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -157.012% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -483.259% |
| MoonLake Immunotherapeutics | -36 Million USD | -450.258% |
| Palisade Bio, Inc. | -12.3 Million USD | -1510.837% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -370.357% |
| Beam Therapeutics Inc. | -132.52 Million USD | -49.504% |
| Neurogene Inc. | -36.31 Million USD | -445.565% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -21.245% |
| AEON Biopharma, Inc. | -52.55 Million USD | -276.994% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -101.874% |
| Sesen Bio, Inc. | -19.88 Million USD | -896.444% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -176.784% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1483.304% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 55.379% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -77.593% |
| Athira Pharma, Inc. | -117.67 Million USD | -68.377% |
| Vaccinex, Inc. | -20.25 Million USD | -878.386% |
| HCW Biologics Inc. | -24.99 Million USD | -692.713% |
| XOMA Corporation | -40.83 Million USD | -385.251% |
| Nektar Therapeutics | -276.05 Million USD | 28.227% |
| Arvinas, Inc. | -367.3 Million USD | 46.057% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -294193.353% |
| Merus N.V. | -154.93 Million USD | -27.878% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -103.364% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -531.298% |
| Rezolute, Inc. | -68.45 Million USD | -189.418% |
| Clene Inc. | -49.5 Million USD | -300.236% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1184.62% |
| BeyondSpring Inc. | -21.02 Million USD | -842.324% |
| Synlogic, Inc. | -57.28 Million USD | -245.891% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1564.843% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1730.159% |
| Peak Bio, Inc. | -1259.26 USD | -15733981.921% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -430.221% |
| Krystal Biotech, Inc. | 10.93 Million USD | 1912.413% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -38.459% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 39.056% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -4189.554% |
| MannKind Corporation | -11.93 Million USD | -1559.683% |
| Ikena Oncology, Inc. | -68.16 Million USD | -190.663% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -842.817% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -113.2% |
| Gossamer Bio, Inc. | -179.81 Million USD | -10.186% |
| CohBar, Inc. | -11.96 Million USD | -1556.337% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -668.315% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -557.158% |
| Legend Biotech Corporation | -518.25 Million USD | 61.769% |
| Mural Oncology plc | -207.44 Million USD | 4.49% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -59.637% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -983.302% |
| Disc Medicine, Inc. | -76.42 Million USD | -159.238% |
| Champions Oncology, Inc. | -7.27 Million USD | -2623.103% |
| REGENXBIO Inc. | -263.49 Million USD | 24.805% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -1766.877% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -317.078% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -421.629% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -97.811% |
| Vaxart, Inc. | -82.46 Million USD | -140.263% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 59463.381% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -427.756% |
| Cellectis S.A. | -101.05 Million USD | -96.057% |
| Longeveron Inc. | -21.41 Million USD | -825.293% |
| Repare Therapeutics Inc. | -93.79 Million USD | -111.238% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 63.033% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -178.398% |
| Revolution Medicines, Inc. | -436.36 Million USD | 54.595% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -2915.264% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -542.788% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -185.77% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -206.082% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -1919.499% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 105.474% |
| Denali Therapeutics Inc. | -145.22 Million USD | -36.433% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -164662.087% |
| Veru Inc. | -93.15 Million USD | -112.697% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -633.039% |
| Cingulate Inc. | -23.53 Million USD | -741.867% |
| Passage Bio, Inc. | -102.06 Million USD | -94.13% |
| Context Therapeutics Inc. | -23.96 Million USD | -726.787% |
| Exicure, Inc. | -16.91 Million USD | -1071.414% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -4.878% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -424.661% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -2944.769% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -7.286% |
| Nuvalent, Inc. | -126.21 Million USD | -56.976% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -1784.172% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -128.056% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -548.681% |
| OmniAb, Inc. | -50.61 Million USD | -291.42% |
| Anew Medical, Inc. | 1.34 Million USD | 14818.767% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1134.858% |
| Lipocine Inc. | -16.35 Million USD | -1111.668% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -198.42% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -211.163% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -369.579% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -313.061% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -899.107% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 63.41% |
| Ocugen, Inc. | -63.07 Million USD | -214.108% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -106.966% |
| Q32 Bio Inc. | -112.96 Million USD | -75.399% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1052.472% |
| Alumis Inc. Common Stock | -154.99 Million USD | -27.834% |
| Equillium, Inc. | -13.33 Million USD | -1385.812% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -228.22% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -2380.434% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -951.035% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -235.353% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -73.001% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -978.102% |
| Dominari Holdings Inc. | -22.88 Million USD | -765.89% |
| Edesa Biotech, Inc. | -8.37 Million USD | -2265.932% |
| vTv Therapeutics Inc. | -20.25 Million USD | -878.435% |
| Bio-Techne Corporation | 168.1 Million USD | 217.863% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 43.726% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 253.767% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -62.628% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -422.241% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -75.896% |
| Nkarta, Inc. | -117.5 Million USD | -68.622% |
| BioCardia, Inc. | -11.57 Million USD | -1612.324% |
| Iterum Therapeutics plc | -38.37 Million USD | -416.361% |